FDA gives preliminary approval to new insomnia drug

03/1/2004 | NYTimes.com

The FDA's "approvable" letter to Sepracor for its Estorra drug allows the Massachusetts drug company to bypass additional clinical or pre-clinical trials for the drug's final approval. The company said it hopes to begin marketing the drug as early as the middle of the year.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR